Kurin Works with The Ohio State University Wexner Medical Center on Patient Safety and Increased Access to High Quality Healthcare
2024年8月6日 - 7:00PM
ビジネスワイヤ(英語)
Kurin, Inc., a certified Minority Business Enterprise, and The
Ohio State University Wexner Medical Center are working together to
reduce contaminated blood cultures and improve high quality
healthcare at Ohio State patient care centers.
“We are pleased to engage with this prestigious organization,”
said Tom Thompson, Kurin Executive VP of Sales. “We are always
impressed when hospitals demonstrate an unwavering commitment to
their patients. We are similarly driven to improving patient
outcomes and helping those who are providing care to these
patients.”
This agreement:
- Provides FDA 510(k)-cleared approaches to address contaminated
blood culture problems.
- Brings clinicians elegantly simple, intuitive technologies that
help simplify clinical workflow, specimen stewardship, and
prevention of sepsis misdiagnosis.
Contaminated blood cultures are a significant problem, as
roughly one-third of the positive results are wrong, exposing these
patients to unnecessary antibiotics, extending hospital stays and
impacting larger community health issues, such as antimicrobial
resistance and life-threatening C. diff. infections. Kurin
Lock® and Kurin Jet™ provide clinicians
the tools they need to address these problems.
About Kurin, Inc.
Kurin, Inc., a certified Minority Business Enterprise (MBE), is
focused on the design, development, manufacture, marketing, and
sale of products that help healthcare providers reduce contaminated
blood cultures. Kurin, manufactured in San Diego, CA, has received
FDA 510(k) market clearance. For more information about Kurin,
visit the website at www.kurin.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240806970282/en/
Matt Heindel Kurin, Inc. 858-752-9514 mattheindel@kurin.com